tci Medicare Compliance & Reimbursement - 2004 Issue 8

Pharmaceuticals: Reimbursement Rates For Popular Meds Under Fire

OIG report claims Medicare is paying higher rates, losing millions.Payments for widely used pharmaceuticals could thin out if the HHS Office of Inspector General gets its way.In a trio of reports released Feb. 2 by the OIG on the pricing of Lupron, ipratropium bromide and albuterol, the agency once again ups the ante on its already longstanding concern over skyrocketing pharmaceutical costs. It wants the Centers for Medicare & Medicaid Services to set "appropriate" payment rates for the drugs after 2004. In 2002, the OIG says Medicare paid $677 million for the cancer drug Lupron - 8...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.

Thank you for choosing Find-A-Code, please Sign In to remove ads.